Patient-Reported Outcomes in the Phase III OASIS-HAE Study of Donidalorsen for Hereditary Angioedema.
Saved in:
| Title: | Patient-Reported Outcomes in the Phase III OASIS-HAE Study of Donidalorsen for Hereditary Angioedema. |
|---|---|
| Authors: | Riedl MA; Division of Allergy and Immunology, University of California San Diego School of Medicine, La Jolla, California, USA., Yarlas A; Ionis, Carlsbad, California, USA., Bordone L; Ionis, Carlsbad, California, USA., Treadwell S; Ionis, Carlsbad, California, USA., Wang S; Ionis, Carlsbad, California, USA., Newman KB; Ionis, Carlsbad, California, USA., Cohn DM; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. |
| Source: | Allergy [Allergy] 2025 Aug; Vol. 80 (8), pp. 2361-2368. Date of Electronic Publication: 2025 Apr 19. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1398-9995 |
|---|---|
| DOI: | 10.1111/all.16563 |
